High Frequency of SARS-CoV-2 RNAemia and Association With Severe Disease. Hogan CA, Stevens BA, Sahoo MK, Huang C, Garamani N, Gombar S, Yamamoto F, Murugesan K, Kurzer J, Zehnder J, Pinsky BA.
Clin Infect Dis. 2020 Sep 23:ciaa1054. doi: 10.1093/cid/ciaa1054. Online ahead of print.PMID: 32965474
Carving out a niche for SARS-CoV-2 plasma RNA testing. Pinsky BA, Hogan CA. Clin Infect Dis. 2020 Sep 17:ciaa1412. doi: 10.1093/cid/ciaa1412. Online ahead of print.PMID: 32941602
Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA. Stevens B, Hogan CA, Sahoo MK, Huang C, Garamani N, Zehnder J, Kurzer J, Pinsky BA.
J Appl Lab Med. 2020 Aug 6:jfaa135. doi: 10.1093/jalm/jfaa135. Online ahead of print.PMID: 32761092
Retrospective Screening for SARS-CoV-2 RNA in California, USA, Late 2019. Hogan CA, Garamani N, Sahoo MK, Huang C, Zehnder J, Pinsky BA. Emerg Infect Dis. 2020 Oct;26(10):2487-2488. doi: 10.3201/eid2610.202296. Epub 2020 Jul 4.PMID: 32620178
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2. Bulterys PL, Garamani N, Stevens B, Sahoo MK, Huang C, Hogan CA, Zehnder J, Pinsky BA. J Clin Virol. 2020 Aug;129:104427. doi: 10.1016/j.jcv.2020.104427. Epub 2020 May 8.PMID: 32535398
Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients. Long DR, Gombar S, Hogan CA, Greninger AL, O'Reilly-Shah V, Bryson-Cahn C, Stevens B, Rustagi A, Jerome KR, Kong CS, Zehnder J, Shah NH, Weiss NS, Pinsky BA, Sunshine J.Clin Infect Dis. 2020 Jun 7:ciaa722. doi: 10.1093/cid/ciaa722. Online ahead of print.PMID: 32506118
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19. Gombar S, Chang M, Hogan CA, Zehnder J, Boyd S, Pinsky BA, Shah NH. J Clin Virol. 2020 Aug;129:104477. doi: 10.1016/j.jcv.2020.104477. Epub 2020 May 30.PMID: 32505778
Fourth-Generation QuantiFERON-TB Gold Plus: What Is the Evidence? Shafeque A, Bigio J, Hogan CA, Pai M, Banaei N.J Clin Microbiol. 2020 Aug 24;58(9):e01950-19. doi: 10.1128/JCM.01950-19. Print 2020 Aug 24.PMID: 32493779
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens. Hogan CA, Garamani N, Lee AS, Tung JK, Sahoo MK, Huang C, Stevens B, Zehnder J, Pinsky BA. J Clin Microbiol. 2020 Jul 23;58(8):e01072-20. doi: 10.1128/JCM.01072-20. Print 2020 Jul 23.PMID: 32461285
Impact of Rapid Antimicrobial Susceptibility Testing in Gram-Negative Rod Bacteremia: a Quasi-experimental Study. Hogan CA, Ebunji B, Watz N, Kapphahn K, Rigdon J, Mui E, Meng L, Alegria W, Holubar M, Deresinski S, Banaei N. J Clin Microbiol. 2020 Aug 24;58(9):e00360-20. doi: 10.1128/JCM.00360-20. Print 2020 Aug 24.PMID: 32434782
Five-minute point-of-care testing for SARS-CoV-2: Not there yet. Hogan CA, Sahoo MK, Huang C, Garamani N, Stevens B, Zehnder J, Pinsky BA. J Clin Virol. 2020 Jul;128:104410. doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.PMID: 32403009
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2. Hogan CA, Sahoo MK, Huang C, Garamani N, Stevens B, Zehnder J, Pinsky BA. J Clin Virol. 2020 Jun;127:104383. doi: 10.1016/j.jcv.2020.104383. Epub 2020 Apr 24.PMID: 32353760
Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2. Hogan CA, Sahoo MK, Pinsky BA. JAMA. 2020 May 19;323(19):1967-1969. doi: 10.1001/jama.2020.5445.PMID: 32250394
Reply to Muller and Chaudhury. Hogan CA, Pinsky BA, Banaei N. Clin Infect Dis. 2020 Mar 4:ciaa220. doi: 10.1093/cid/ciaa220. Online ahead of print.PMID: 32140706
Clinical Impact of Metagenomic Next-Generation Sequencing of Plasma Cell-Free DNA for the Diagnosis of Infectious Diseases: A Multicenter Retrospective Cohort Study. Hogan CA, Yang S, Garner OB, Green DA, Gomez CA, Dien Bard J, Pinsky BA, Banaei N. Clin Infect Dis. 2020 Jan 14:ciaa035. doi: 10.1093/cid/ciaa035. Online ahead of print.PMID: 31942944
Rapid identification of pathogenic bacteria using Raman spectroscopy and deep learning. Ho CS, Jean N, Hogan CA, Blackmon L, Jeffrey SS, Holodniy M, Banaei N, Saleh AAE, Ermon S, Dionne J. Nat Commun. 2019 Oct 30;10(1):4927. doi: 10.1038/s41467-019-12898-9.PMID: 31666527
Investigation of Preanalytical Variables Impacting Pathogen Cell-Free DNA in Blood and Urine. Murugesan K, Hogan CA, Palmer Z, Reeve B, Theron G, Andama A, Somoskovi A, Steadman A, Madan D, Andrews J, Croda J, Sahoo MK, Cattamanchi A, Pinsky BA, Banaei N. J Clin Microbiol. 2019 Oct 23;57(11):e00782-19. doi: 10.1128/JCM.00782-19. Print 2019 Nov.PMID: 31511335
Dual Reporting of Clostridioides difficile PCR and Predicted Toxin Result Based on PCR Cycle Threshold Reduces Treatment of Toxin-Negative Patients without Increases in Adverse Outcomes. Hitchcock MM, Holubar M, Hogan CA, Tompkins LS, Banaei N. J Clin Microbiol. 2019 Oct 23;57(11):e01288-19. doi: 10.1128/JCM.01288-19. Print 2019 Nov.PMID: 31511334
Dipylidium caninum Infection. Hogan CA, Schwenk H. N Engl J Med. 2019 May 23;380(21):e39. doi: 10.1056/NEJMicm1813985.PMID: 31116922
Reproducibility of positive results for rare pathogens on the FilmArray GI Panel. Hitchcock MM, Hogan CA, Budvytiene I, Banaei N. Diagn Microbiol Infect Dis. 2019 Sep;95(1):10-14. doi: 10.1016/j.diagmicrobio.2019.03.013. Epub 2019 Mar 29.PMID: 31029490
Rapid antimicrobial susceptibility testing by VITEK®2 directly from blood cultures in patients with Gram-negative rod bacteremia. Hogan CA, Watz N, Budvytiene I, Banaei N. Diagn Microbiol Infect Dis. 2019 94:116-121. PMID: 30711413
Higher Positivity Rate with Fourth-Generation QuantiFERON-TB Gold Plus Assay in Low-Risk U.S. Health Care Workers. Hogan CA, Tien S, Pai M, Banaei N. J Clin Microbiol. 2019 57(1):e01688-18. PMID: 30355762